Phathom Pharmaceuticals Inc

Insightful look at Phathom Pharma’s insider trades: Breedlove’s 11% stake boost amid price swings, highlighting executive confidence and future upside potential.

Phathom Pharmaceuticals insider buy: 8,750 shares at $10.30—below $15.14—signals long‑term confidence in GI therapeutics and a potential value play amid low P/E, regulatory hurdles.